Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Professor Teresa Lambe elected to Fellowship of Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

Photo of Professor Teresa Lambe© CREDIT: JOHN CAIRNS/UNIVERSITY OF OXFORD

 

Professor Lambe is one of 58 exceptional biomedical and health scientists elected as Fellows for their outstanding contributions to advancing ground-breaking research discoveries, and translating developments into benefits for patients and wider society. The award recognises her unique contributions to understanding human health and controlling disease through vaccination.

Professor Teresa Lambe said: "It is a huge honour to be elected as a Fellow of the Royal Academy of Medical Sciences. I have been fortunate to work with incredibly talented colleagues over the course of my career both in the UK and worldwide, and I’m incredibly proud that this work has been recognised.”

Professor Lambe’s research focuses on delineating the protective immune response post infection and using these findings to rationally design vaccination strategies to prevent disease.

Her group is currently developing and testing vaccines against a number of outbreak pathogens including Crimean-Congo haemorrhagic fever, Ebola virus, Marburg virus and Coronaviruses. A number of these vaccines have progressed to clinical trial assessment, including vaccines against Ebola and Marburg virus.

Professor Andrew Morris PMedSci, President of the Academy of Medical Sciences, said: “It is an honour to welcome these brilliant minds to our Fellowship. Our new Fellows lead pioneering work in biomedical research and are driving remarkable improvements in healthcare. We look forward to working with them, and learning from them, in our quest to foster an open and progressive research environment that improves the health of people everywhere through excellence in medical science.”

The new Fellows will be formally admitted to the Academy at a ceremony on Wednesday 18 September 2024.

The Academy of Medical Sciences is the independent, expert body representing the diversity of medical science in the UK. Its mission is to advance biomedical and health research and its translation into benefits for society. The Academy's elected Fellows are the most influential scientists in the UK and worldwide, drawn from the NHS, academia, industry and the public service.